CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 43 enrolled
Drug / intervention
mHealthdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05757453
NCT05757453Phase 1Completed
CompareCT.gov

BoostOne Study (MHealth)

NXTech·interventional·Posted Mar 7, 2023·Updated Dec 18, 2024

In Brief

A Phase 1 clinical trial evaluating mHealth for Addiction. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The purpose of this research is to examine the potential for a new software-based behavioral support approach, for individuals with opioid use disorder, as an addition to usual care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAddiction
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
2023202420252026
First PostedMar 7, 2023
Enrollment StartApr 18, 2022
Primary CompletionMar 30, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.3 years ago

Interventions

mHealthdevice

Mobile platform